News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Fulltext search Search More than one hundred patients with locally advanced and borderline resectable cancer 23/08/2024 A clinical trial has led to approval of the first drug for advanced fatty liver disease 26/03/2024 New treatment based on nanoparticles for chronic liver disease 14/11/2023 Vall d'Hebron discovers a new antibody for the diagnosis of patients with scleroderma 24/10/2023 Vall d’Hebron acull una sessió sobre els assaigs clínics en fetge gras no alcohòlicl 24/05/2023 COVID-19 increases the risk of developing irritable bowel syndrome in the long term 17/03/2023 A Vall d'Hebron project receives a grant by the European Crohn's and Colitis Organization 06/03/2023 Two Vall d’Hebron research projects get grants from the City Council and the “La Caixa 02/03/2023 Collaborative trial platforms, key in the NASH research 14/11/2022 A study by Dr. Luis G Alcalá, selected for the Young Investigator Forum 01/08/2022 Vall d’Hebron hosted IMI-2 EU-PEARL work meeting about platforms for clinical trials 17/05/2022 Test of Vall d’Hebron and GoodGut to diagnose irritable bowel syndrome 16/03/2022 Hepatology is the Service with the highest participation in liver disease trials 22/02/2022 RESPONSE, a global phase III clinical trial for primary biliary cholangitis 03/02/2022 Study from Vall d'Hebron determines that the Mediterranean diet increases the colon's microbiota 17/10/2021 Vall d'Hebron named by CatSalut as a Clinical Expertise Unit (UEC) in the fields of rare immune diseases within the area of systemic autoimmune diseases. 17/08/2021 Vall d'Hebron releases four innovative works on different systemic diseases 04/08/2021 Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis 21/06/2021 Study questions the concept that high fat meals induce satisfaction and digestive well-being 18/04/2018